TUM – TUM – Menu


New research results or upcoming events: Stay up-to-date on what is happening at TUM.


TUMcampus • Faszination Forschung • KontakTUM

Fahne der TUM

Shanhai-Ranking, THE, CHE and more ranking results


Facebook, Twitter,
YouTube & Instagram

Wissenschaftlerin an einer Tafel mit Formeln

Numbers of students, staff, nobel laureates and more

News releases

  • German Research Foundation awards top science prize to TUM physicist:

    Physicist Franz Pfeiffer receives 2011 Leibniz Prize

    Physicist Franz Pfeiffer is one of the ten winners of the 2011 Leibniz Prize, the German Research Foundation (DFG) has announced. The 38-year-old physicist, holds the Chair for Biomedical Physics at the Technische Universitaet Muenchen (TUM). The price honors his fundamental and applied research in phase-contrast X-ray imaging, which promises significant progress toward early detection of tumors. The Leibniz Prize is Germany's most renowned scientific award and brings each recipient 2.5 million euros in prize money.

  • Anti-inflammatory agent with side effects

    Rapid test to save Indian vultures from extinction

    Oriental white-backed vultures on the bar

    Vulture population declined at a catastrophic rate on the Indian subcontinent over the past fifteen years. In the meantime three species are facing extinction. In 2004 scientists in the United States identified the cause: the drug Diclofenac. The use of this anti-inflammatory agent in veterinary medicine has meanwhile been banned, however, due to the lack of a suitable detection method, the ban could so far not been enforced effectively. This gap is now being closed with a rapid test developed by scientists at the Technische Universität München (TUM).

  • New approach for cancer medication discovered

    TUM researchers demonstrate rocking movement in the anti-stress protein Hsp90

    Diagram of the rocking motion of HSP90 observed in yeast.

    The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universität München (TUM) uncovered this protein’s mode of operation some time ago – but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.

  • Improved security for dairy products

    Minilab identifies antibiotic residues in milk

    No one wants antibiotic residues in their milk. But antibiotics are sometimes used even in the dairy barn. The routine tests conducted nowadays take hours to produce a result and do not test for all of the typical antibiotics. This gap can now be closed, thanks to a fully automated minilab developed by scientists from the TUM in cooperation with the LMU München and gwk Praezisionstechnik GmbH.

  • TUM researchers present initial data from successful ESA mission

    GOCE satellite determines gravitational force in the Himalayas

    Satellite GOCE orbits the earth

    ESA's GOCE satellite has been orbiting the Earth for more than a year and surveying its gravitational field more accurately than any instrument previously. The goal of the researchers – including scientists at the Technische Universität München (TUM) – is to determine the gravitational force in precise detail even in pathless places like the Himalayas. Evaluations of the first data from the satellite indicate that current models of the gravitational field in some regions can be fundamentally revised. On that basis, researchers expect to develop a better understanding of many geophysical processes, including for example earthquakes and ocean circulation. Another success: The satellite will probably manage to work in space for a much longer period than intended.

  • General Electric collaborates in research with TU München

    Neutrons peer into the heart of a rechargeable battery for hybrid locomotives

    Dr. Michael Hofmann examines the batteries with STRESS-SPEC (Photo: Gilles / TU München)

    Rechargeable batteries may soon provide greater energy efficiency not only for road traffic, but also for rail transport. Scientists at the research neutron source FRM II of the Technische Universität München (TUM) are taking a closer look at a high performance rechargeable battery for future hybrid locomotives. The focus is on a sodium/iron chloride battery manufactured by General Electric (GE). The study reveals the distribution of chemical substances within the battery during various states of charge. 

  • Activation of heat shock protein explained:

    Symmetrical protein activated by break in symmetry

    The unusual aysmetric activation of hsp90.

    Mucoviscidosis, a disease better known as cystic fibrosis, is the most common hereditary metabolic disease in Europe. The defective regulation of the heat shock protein Hsp90 by the partner protein Aha1 is a trigger of the disease. Scientists at the Technische Universität München (TUM) have succeeded in explaining the mechanism behind this reaction. They have reported their findings in the current edition of the journal Molecular Cell.

  • Academy Award for Professor Reimar Lenz

    TUM professor to collect an Oscar for ARRI

    Prof. Dr. Reimar Lenz on stage at the award ceremony.

    An Oscar in the Scientific and Engineering Awards category will be presented this year to TUM Adjunct Professor Reimar Lenz. The Academy of Motion Picture Arts and Sciences will honor the pioneer in the field of digital photography for his contribution to the development of the ARRISCAN film scanner. The scanner enables high-speed, high-precision, and high-resolution scanning of analog feature film stock. The Oscar will also be awarded to Michael Cieslinski and Bernd Brauner from the Munich-based ARRI group (Arnold & Richter Cine Technik), who worked with Professor Lenz on the development of the scanner.

  • TUM researchers guide stock index development, will define composition

    German stock exchange to create two new "family firm" indices

    Prof. Christoph Kaserer and Prof. Ann-Kristin Achleitner.

    In Frankfurt, Deutsche Börse AG has announced the launch of two new stock indices based on research done in Munich – at TUM, the Technische Universität München. Beginning on January 4, 2010, the DAXplus Family and the DAXplus Family 20 will become part of the DAX index family. The first index is tracking all listed German family firms, as defined by criteria developed at the university's Center for Entrepreneurial and Financial Studies (CEFS). The second one is focused on the 20 largest German “family firms”.

  • Learning from evolution

    Fine-tuning an anti-cancer drug

    Salinosporamide A locks the proteasome like a key

    Cancer remains a deadly threat despite the best efforts of science. New hopes were raised a few years ago with the discovery that the uncontrolled growth of cancer cells could be thwarted by blocking the action of proteasomes. Biochemists at the Technische Universitaet Muenchen (TUM) have illuminated a reaction pathway that does just that, in collaboration with researchers from Nereus Pharmaceuticals, based in San Diego, California. In the current issue of the Journal of Medicinal Chemistry, they report insights that could potentially lead to the development of custom-tailored anti-cancer drugs.


Corporate Communications Center
Technical University of Munich
Arcisstr. 21
D-80333 Munich
Tel. +49 89 289 22778
Fax +49 89 289 23388


Further Information


Corporate Communications Center
Technical University of Munich
Arcisstr. 21
D-80333 Munich
Tel. +49 89 289 22778
Fax +49 89 289 23388